Skip to content

Clinical trials

Recruiting Leukemia, Myelomonocytic, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Status: Recruiting Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20151
20161
20171
20184
20195
20205
20215
20225
20233
20249
202510
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center10
Fred Hutchinson Cancer Center7
Mayo Clinic3
City of Hope Medical Center2
Aptose Biosciences Inc.1
Blueprint Medicines Corporation1
Center for International Blood and Marrow Transplant Research1
Centre Hospitalier Universitaire de Nice1
Clinical Hub for Interventional Research (CHOIR)1
Cogent Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic60
Leukemia, Myeloid, Acute36
Myelodysplastic Syndromes34
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Leukemia, Biphenotypic, Acute11
Primary Myelofibrosis11
Anemia, Refractory, with Excess of Blasts9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive9
Myeloproliferative Disorders8
Hodgkin Disease7

Trials

Showing 76 to 60 of 60. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.